Journey Medical Corp. (DERM)
4.95
+0.31
(+6.68%)
USD |
NASDAQ |
Apr 02, 16:00
4.96
+0.01
(+0.20%)
After-Hours: 20:00
Journey Medical EPS Diluted (Quarterly) : -0.0459 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fortress Biotech, Inc. | -0.1976 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.247M |
| Revenue (Quarterly) | 16.08M |
| Total Expenses (Quarterly) | 17.33M |
| Enterprise Value | 136.59M |
| Gross Profit Margin (Quarterly) | 59.54% |
| Profit Margin (Quarterly) | -7.76% |
| Earnings Yield | -9.11% |
| Normalized Earnings Yield | -9.105 |